Fas	O
-	O
signaling	O
and	O
effects	O
on	O
receptor	O
tyrosine	O
kinase	O
signal	O
transduction	O
in	O
human	O
breast	B-Cell
epithelial	I-Cell
cells	I-Cell
.	O

Fas	O
-	O
mediated	O
cell	B-Cell
death	O
was	O
examined	O
in	O
MCF	B-Cell
-	I-Cell
10AT	I-Cell
preneoplastic	I-Cell
human	I-Cell
breast	I-Cell
epithelial	I-Cell
cells	I-Cell
.	O

Treatment	O
with	O
anti	O
-	O
Fas	O
for	O
48	O
h	O
induced	O
apoptosis	O
with	O
cells	B-Cell
exhibiting	O
typical	O
apoptotic	O
features	O
including	O
loss	O
of	O
cell	B-Cell
contact	O
,	O
condensation	O
of	O
chromatin	B-Cellular_component
,	O
and	O
increased	O
staining	O
of	O
the	O
nuclear	B-Cellular_component
membrane	I-Cellular_component
.	O

DNA	O
fragmentation	O
occurred	O
in	O
response	O
to	O
anti	O
-	O
Fas	O
treatment	O
.	O

Anti	O
-	O
Fas	O
treatment	O
resulted	O
in	O
decreased	O
p53	O
protein	O
levels	O
,	O
while	O
bcl	O
-	O
2	O
and	O
bax	O
protein	O
levels	O
remained	O
unaffected	O
.	O

Cells	B-Cell
treated	O
with	O
anti	O
-	O
Fas	O
also	O
exhibited	O
increased	O
tyrosine	O
phosphorylation	O
of	O
the	O
c	O
-	O
met	O
growth	O
factor	O
receptor	O
tyrosine	O
kinase	O
.	O

Immunoprecipitation	O
experiments	O
demonstrated	O
that	O
Fas	O
associated	O
with	O
c	O
-	O
erbB2	O
and	O
c	O
-	O
met	O
in	O
untreated	O
cells	B-Cell
.	O

Treatment	O
with	O
anti	O
-	O
Fas	O
,	O
however	O
,	O
significantly	O
decreased	O
Fas	O
-	O
c	O
-	O
erbB2	O
and	O
Fas	O
-	O
c	O
-	O
met	O
association	O
.	O

Anti	O
-	O
Fas	O
treatment	O
of	O
these	O
cells	B-Cell
caused	O
a	O
significant	O
decrease	O
in	O
p120	O
-	O
GAP	O
levels	O
,	O
ERK	O
-	O
1	O
levels	O
,	O
and	O
phosphorylation	O
,	O
as	O
well	O
as	O
Grb2	O
-	O
Sosl	O
and	O
MEK	O
-	O
1	O
-	O
ERK	O
-	O
1	O
association	O
.	O

These	O
results	O
show	O
that	O
Fas	O
-	O
signaling	O
exerted	O
a	O
suppressive	O
effect	O
on	O
p53	O
levels	O
and	O
on	O
downstream	O
effectors	O
of	O
receptor	O
tyrosine	O
kinase	O
signal	O
transduction	O
,	O
thereby	O
ensuring	O
cell	B-Cell
death	O
.	O

